Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...

A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A new study from Memorial Sloan Kettering Cancer Center shows good results for patients with pancreatic cancer. They used a ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

FRIDAY, Feb. 21, 2025 (HealthDay News) -- Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial ...

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small ...